Boditech Med Inc. (KOSDAQ:206640)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,420
-200 (-1.88%)
Jul 21, 2026, 3:30 PM KST
Market Cap216.06B -31.0%
Revenue (ttm)165.84B +15.0%
Net Income25.99B -6.7%
EPS1,200.55 -5.6%
Shares Out 20.34M
PE Ratio8.85
Forward PEn/a
Dividend150.00 (1.41%)
Ex-Dividend DateMar 31, 2026
Volume56,348
Open10,530
Previous Close10,620
Day's Range10,270 - 10,700
52-Week Range9,580 - 15,000
Beta0.38
Analystsn/a
Price Targetn/a
Earnings DateAug 12, 2026

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;... [Read more]

Sector Healthcare
Founded 1998
Employees 541
Stock Exchange KOSDAQ
Ticker Symbol 206640
Full Company Profile

Financial Performance

In 2025, Boditech Med's revenue was 162.09 billion, an increase of 17.32% compared to the previous year's 138.16 billion. Earnings were 23.65 billion, a decrease of -13.23%.

Financial Statements